economic losses to the cattle industry. Control of bovine babesiosis has been hindered by
the limited treatment selection for B. bovis, thus, new options are urgently needed. We
explored the drug library and unbiasedly screened 640 food and drug administration (FDA)
approved drug compounds for their inhibitory activities against B. bovis in vitro. The initial
screening identified 13 potentially effective compounds. Four potent compounds, namely …